Costs of illness and care in Parkinson's Disease: An evaluation in six countries

Sonja von Campenhausen; Yaroslav Winter; Antonio Rodrigues e Silva; Christina Sampaio; Evzen Ruzicka; Paolo Barone; Werner Poewe; Alla Guekht; Céu Mateus; Karl P. Pfeiffer; Karin Berger; Jana Skoupa; Kai Bötzel; Sabine Geiger-Gritsch; Uwe Siebert; Monika Balzer-Geldsetzer; Wolfgang H. Oertel; Richard Dodel; Jens P. Reese

doi:10.1016/j.euroneuro.2010.08.002

Costs of illness and care in Parkinson's Disease: An evaluation in six countries

Sonja von Campenhausen, Yaroslav Winter, Antonio Rodrigues e Silva, Christina Sampaio, Evzen Ruzicka, Paolo Barone, Werner Poewe, Alla Guekht, Céu Mateus, Karl P. Pfeiffer, Karin Berger, Jana Skoupa, Kai Bötzel, Sabine Geiger-Gritsch, Uwe Siebert, Monika Balzer-Geldsetzer, Wolfgang H. Oertel, Richard Dodel, Jens P. Reese

Escola Nacional de Saúde Pública (ENSP)

Research output: Contribution to journal › Article

55 Citations (Scopus)

129 Downloads (Pure)

Abstract

We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

Original language	English
Pages (from-to)	180-191
Number of pages	12
Journal	European Neuropsychopharmacology
Volume	21
Issue number	2
DOIs	https://doi.org/10.1016/j.euroneuro.2010.08.002
Publication status	Published - 1 Feb 2011

Keywords

Care
Cost
Cost-of-illness
Economic burden
Europe
Parkinson's Disease

Access to Document

10.1016/j.euroneuro.2010.08.002Licence: Unspecified

Sonja Eur Neuropsychopharmacology 2011 21 2 180Final published version, 0.98 MBLicence: Unspecified

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Costs of illness and care in Parkinson's Disease: An evaluation in six countries'. Together they form a unique fingerprint.

Cite this

von Campenhausen, S., Winter, Y., Rodrigues e Silva, A., Sampaio, C., Ruzicka, E., Barone, P., ... Reese, J. P. (2011). Costs of illness and care in Parkinson's Disease: An evaluation in six countries. European Neuropsychopharmacology, 21(2), 180-191. https://doi.org/10.1016/j.euroneuro.2010.08.002

von Campenhausen, Sonja ; Winter, Yaroslav ; Rodrigues e Silva, Antonio ; Sampaio, Christina ; Ruzicka, Evzen ; Barone, Paolo ; Poewe, Werner ; Guekht, Alla ; Mateus, Céu ; Pfeiffer, Karl P. ; Berger, Karin ; Skoupa, Jana ; Bötzel, Kai ; Geiger-Gritsch, Sabine ; Siebert, Uwe ; Balzer-Geldsetzer, Monika ; Oertel, Wolfgang H. ; Dodel, Richard ; Reese, Jens P. / Costs of illness and care in Parkinson's Disease : An evaluation in six countries. In: European Neuropsychopharmacology. 2011 ; Vol. 21, No. 2. pp. 180-191.

@article{4b1d7aa0bf29449f8365f033d13d9080,

title = "Costs of illness and care in Parkinson's Disease: An evaluation in six countries",

abstract = "We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60{\%} to 70{\%} and indirect costs about 30{\%} to 40{\%} of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.",

keywords = "Care, Cost, Cost-of-illness, Economic burden, Europe, Parkinson's Disease",

author = "{von Campenhausen}, Sonja and Yaroslav Winter and {Rodrigues e Silva}, Antonio and Christina Sampaio and Evzen Ruzicka and Paolo Barone and Werner Poewe and Alla Guekht and C{\'e}u Mateus and Pfeiffer, {Karl P.} and Karin Berger and Jana Skoupa and Kai B{\"o}tzel and Sabine Geiger-Gritsch and Uwe Siebert and Monika Balzer-Geldsetzer and Oertel, {Wolfgang H.} and Richard Dodel and Reese, {Jens P.}",

year = "2011",

month = "2",

day = "1",

doi = "10.1016/j.euroneuro.2010.08.002",

language = "English",

volume = "21",

pages = "180--191",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

number = "2",

}

von Campenhausen, S, Winter, Y, Rodrigues e Silva, A, Sampaio, C, Ruzicka, E, Barone, P, Poewe, W, Guekht, A, Mateus, C, Pfeiffer, KP, Berger, K, Skoupa, J, Bötzel, K, Geiger-Gritsch, S, Siebert, U, Balzer-Geldsetzer, M, Oertel, WH, Dodel, R & Reese, JP 2011, 'Costs of illness and care in Parkinson's Disease: An evaluation in six countries', European Neuropsychopharmacology, vol. 21, no. 2, pp. 180-191. https://doi.org/10.1016/j.euroneuro.2010.08.002

Costs of illness and care in Parkinson's Disease : An evaluation in six countries. / von Campenhausen, Sonja; Winter, Yaroslav; Rodrigues e Silva, Antonio; Sampaio, Christina; Ruzicka, Evzen; Barone, Paolo; Poewe, Werner; Guekht, Alla; Mateus, Céu; Pfeiffer, Karl P.; Berger, Karin; Skoupa, Jana; Bötzel, Kai; Geiger-Gritsch, Sabine; Siebert, Uwe; Balzer-Geldsetzer, Monika; Oertel, Wolfgang H.; Dodel, Richard; Reese, Jens P.

In: European Neuropsychopharmacology, Vol. 21, No. 2, 01.02.2011, p. 180-191.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Costs of illness and care in Parkinson's Disease

T2 - An evaluation in six countries

AU - von Campenhausen, Sonja

AU - Winter, Yaroslav

AU - Rodrigues e Silva, Antonio

AU - Sampaio, Christina

AU - Ruzicka, Evzen

AU - Barone, Paolo

AU - Poewe, Werner

AU - Guekht, Alla

AU - Mateus, Céu

AU - Pfeiffer, Karl P.

AU - Berger, Karin

AU - Skoupa, Jana

AU - Bötzel, Kai

AU - Geiger-Gritsch, Sabine

AU - Siebert, Uwe

AU - Balzer-Geldsetzer, Monika

AU - Oertel, Wolfgang H.

AU - Dodel, Richard

AU - Reese, Jens P.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

AB - We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

KW - Care

KW - Cost

KW - Cost-of-illness

KW - Economic burden

KW - Europe

KW - Parkinson's Disease

UR - http://www.scopus.com/inward/record.url?scp=78751624162&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2010.08.002

DO - 10.1016/j.euroneuro.2010.08.002

M3 - Article

C2 - 20888737

AN - SCOPUS:78751624162

VL - 21

SP - 180

EP - 191

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 2

ER -